Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 Adenocarcinoma?

Overview of attention for article published in Annals of Surgical Oncology, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 39,475 followers.

RT @AnnSurgOncol: EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t">https://t…

RT SocSurgOnc RT AnnSurgOncol: EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t.co/0xuPVNqPHU">https://t.co/0xuPVNqPHU McMastersKelly SocSurgOnc

RT @AnnSurgOncol: EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t">https://t…

RT @AnnSurgOncol: EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t">https://t…

RT @AnnSurgOncol: EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t">https://t…

EDITORIAL: Is a Novel Nomogram Better Than TNM Staging at Predicting Survival in Siewert Type 2 #Adenocarcinoma? target="_blank" href="https://t.co/zWdPhhISOZ">https://t.co/zWdPhhISOZ @McMastersKelly @SocSurgOnc